299 related articles for article (PubMed ID: 10464671)
1. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
Roa BB; Savino CV; Richards CS
Genet Test; 1999; 3(2):219-21. PubMed ID: 10464671
[TBL] [Abstract][Full Text] [Related]
2. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin.
Shahrabani-Gargir L; Shomrat R; Yaron Y; Orr-Urtreger A; Groden J; Legum C
Genet Test; 1998; 2(4):293-6. PubMed ID: 10464606
[TBL] [Abstract][Full Text] [Related]
3. Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population.
Li L; Eng C; Desnick RJ; German J; Ellis NA
Mol Genet Metab; 1998 Aug; 64(4):286-90. PubMed ID: 9758720
[TBL] [Abstract][Full Text] [Related]
4. A rapid method for detecting the predominant Ashkenazi Jewish mutation in the Bloom's syndrome gene.
Straughen JE; Johnson J; McLaren D; Proytcheva M; Ellis N; German J; Groden J
Hum Mutat; 1998; 11(2):175-8. PubMed ID: 9482582
[TBL] [Abstract][Full Text] [Related]
5. Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel.
Peleg L; Pesso R; Goldman B; Dotan K; Omer M; Friedman E; Berkenstadt M; Reznik-Wolf H; Barkai G
Isr Med Assoc J; 2002 Feb; 4(2):95-7. PubMed ID: 11876000
[TBL] [Abstract][Full Text] [Related]
6. The Ashkenazic Jewish Bloom syndrome mutation blmAsh is present in non-Jewish Americans of Spanish ancestry.
Ellis NA; Ciocci S; Proytcheva M; Lennon D; Groden J; German J
Am J Hum Genet; 1998 Dec; 63(6):1685-93. PubMed ID: 9837821
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Bloom syndrome heterozygotes among Ashkenazi Jews.
Oddoux C; Clayton CM; Nelson HR; Ostrer H
Am J Hum Genet; 1999 Apr; 64(4):1241-3. PubMed ID: 10090915
[No Abstract] [Full Text] [Related]
8. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
9. Linkage disequilibrium between the FES, D15S127, and BLM loci in Ashkenazi Jews with Bloom syndrome.
Ellis NA; Roe AM; Kozloski J; Proytcheva M; Falk C; German J
Am J Hum Genet; 1994 Sep; 55(3):453-60. PubMed ID: 8079989
[TBL] [Abstract][Full Text] [Related]
10. Relatively common mutations of the Bloom syndrome gene in the Japanese population.
Kaneko H; Isogai K; Fukao T; Matsui E; Kasahara K; Yachie A; Seki H; Koizumi S; Arai M; Utunomiya J; Miki Y; Kondo N
Int J Mol Med; 2004 Sep; 14(3):439-42. PubMed ID: 15289897
[TBL] [Abstract][Full Text] [Related]
11. Localization of cancer susceptibility genes by genome-wide single-nucleotide polymorphism linkage-disequilibrium mapping.
Mitra N; Ye TZ; Smith A; Chuai S; Kirchhoff T; Peterlongo P; Nafa K; Phillips MS; Offit K; Ellis NA
Cancer Res; 2004 Nov; 64(21):8116-25. PubMed ID: 15520224
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome.
Baris HN; Kedar I; Halpern GJ; Shohat T; Magal N; Ludman MD; Shohat M
Isr Med Assoc J; 2007 Dec; 9(12):847-50. PubMed ID: 18210922
[TBL] [Abstract][Full Text] [Related]
13. Carrier screening of RTEL1 mutations in the Ashkenazi Jewish population.
Fedick AM; Shi L; Jalas C; Treff NR; Ekstein J; Kornreich R; Edelmann L; Mehta L; Savage SA
Clin Genet; 2015 Aug; 88(2):177-81. PubMed ID: 25047097
[TBL] [Abstract][Full Text] [Related]
14. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.
Zauber NP; Sabbath-Solitare M; Marotta S; Zauber AG; Foulkes W; Chan M; Turner F; Bishop DT
Cancer; 2005 Aug; 104(4):719-29. PubMed ID: 15959913
[TBL] [Abstract][Full Text] [Related]
16. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
Roa BB; Boyd AA; Volcik K; Richards CS
Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
[TBL] [Abstract][Full Text] [Related]
17. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
[TBL] [Abstract][Full Text] [Related]
18. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population.
Whitney MA; Jakobs P; Kaback M; Moses RE; Grompe M
Hum Mutat; 1994; 3(4):339-41. PubMed ID: 8081385
[TBL] [Abstract][Full Text] [Related]
19. Study of carrier frequency of Warsaw breakage syndrome in the Ashkenazi Jewish population and presentation of two cases.
Rabin R; Hirsch Y; Johansson MM; Ekstein J; Zeevi DA; Keena B; Zackai EH; Pappas J
Am J Med Genet A; 2019 Oct; 179(10):2144-2151. PubMed ID: 31287223
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of Bloom syndrome and function of the causative gene, BLM helicase.
Kaneko H; Kondo N
Expert Rev Mol Diagn; 2004 May; 4(3):393-401. PubMed ID: 15137905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
